Granted Patent B2

US 12,241,124 · App. 17/264,217 · Granted Mar 4, 2025

Inventors: Shimobi Onuoha (London, GB); Meggan Czapiga (London, GB); Biao Ma (London, GB)

Assignee: AUTOLUS LIMITED

C12Q1/6881C12Q1/6886C12Q2600/106C12Q2600/156

Abstract

Claims (10)

1. A method of treating peripheral T cell lymphoma (PTCL) in a subject comprising:

(1) determining the T cell receptor β chain constant region (TRBC) gene type of a PTCL cell from said subject is a TRBC1 type or a TRBC2 type with a method comprising:

(a) determining the J gene type expressed in said cell by:

(i) extracting nucleic acid of the J gene from said cell;

(ii) sequencing at least a segment of the J gene from said nucleic acid;

(iii) comparing the nucleotide sequence determined in (ii) to one or more J gene reference nucleotide sequence(s), wherein the reference nucleotide sequences comprise SEQ ID NOs: 1-16; and

(iv) identifying the J gene type from sequence identity of the nucleotide sequence of the segment of said J gene of (ii) to the J gene reference nucleotide sequence(s) of (iii), and

(b) inferring from (a) the TRBC gene type expressed in said cell,

wherein the TRBC gene in the cell from the subject is determined to be a TRBC1 gene when the J gene sequence is determined to comprise the nucleotide sequence of one of SEQ ID NO: 1-7 or the TRBC gene in the cell from the subject is determined to be a TRBC2 gene when the J gene sequence is determined to comprise the nucleotide sequence of one of SEQ ID NO: 8-16; and

(2) administering to said subject a CAR T cell targeted to the TRBC type determined in (1).

Assignments (2)

Priority Claims (1)

Continuity (1)

References Cited (28)